Business
Gain Therapeutics to Participate at Drug Discovery Innovation Programme 2025
BETHESDA, Md., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric, small-molecule therapies, today announced that Dr. Rinaldo Montalvão, Director of Artificial Intelligence at Gain Therapeutics, will deliver a talk at the WORLD BI sponsored Drug Discovery Innovation Programme (DDIP) 2025, being held September 25th -26th in Barcelona,
About this update from Gain Therapeutics, Inc.
[{"type":"image","alt":"Gain Therapeutics, Inc.","displaySize":"","headline":null,"caption":"Gain Therapeutics, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":150,"height":72,"url":"https://media.zenfs.com/en/globenewswire.com/71d53e58a7e975cfd00a1328d22e0699"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/nsPBXqjXYfLs4XgIgz1iUg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTEwMTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/71d53e58a7e975cfd00a1328d22e0699","width":150,"height":72}},"lazy":false},{"type":"text","content":"BETHESDA, Md., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric, small-molecule therapies, today announced that Dr. Rinaldo Montalvão, Director of Artificial Intelligence at Gain Therapeutics, will deliver a talk at the WORLD BI sponsored Drug Discovery Innovation Programme (DDIP) 2025, being held September 25th -26th in Barcelona, Spain.","length":507,"tagName":"p"},{"type":"text","content":"Details on the talk are as follows:","length":35,"tagName":"p"},{"type":"text","content":"Track: AI and Automation in Drug Discovery","length":42,"tagName":"p"},{"type":"text","content":"Title: “Transforming Drug Discovery: Generative Models and Electrostatic Complementarity”","length":89,"tagName":"p"},{"type":"text","content":"Date: Friday, September 26, 9:20am CEST","length":39,"tagName":"p"},{"type":"text","content":"About WORLD BI and DDIP 2025","length":28,"tagName":"p"},{"type":"text","content":"WORLD BI connects global leaders through conferences that deliver value to hundreds of delegates each year. The events allow for networking with industry decision-makers to share knowledge, and spark new ideas.","length":210,"tagName":"p"},{"type":"text","content":"World BI delivers Drug Discovery Conferences for scientists, sponsors, engineers, and exhibitors from the pharma, biotech, life sciences, healthcare, and bioinformatics industries. These Drug Discovery conferences focus on a range of areas, including but not limited to drug delivery, pharmacology, organic synthesis, structural biology, and medicinal chemistry. They also highlight great achievements in preparing cardiovascular, anticancer, anti-infective, and CNS drugs.","length":483...